triiodothyronine has been researched along with Urogenital Neoplasms in 1 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Urogenital Neoplasms: Tumors or cancer of the UROGENITAL SYSTEM in either the male or the female.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunzendorfer, U | 1 |
| Knöner, M | 1 |
| Drahowsky, D | 1 |
1 trial available for triiodothyronine and Urogenital Neoplasms
| Article | Year |
|---|---|
Prolactin, LH, TSH, T3 and T4 in patients with urogenital carcinomas.
Topics: Adenocarcinoma; Female; Humans; Kidney Neoplasms; Luteinizing Hormone; Male; Prolactin; Testicular N | 1979 |